| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9404401 | Surgery | 2005 | 9 Pages |
Abstract
These data offer functional evidence that implicates MUC1 over-expression as a key molecular event in the pathogenesis of aggressive TC. Retrovirally delivered anti-MUC1 RNAi is effective in silencing MUC1 and merits further investigation to establish therapeutic efficacy and safety in anticipation of potential clinical application.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Kepal N. MD, Ellie MD, Volkert B. MD, Ashok R. MD, Jatin P. MD, Ronald MD, Bhuvanesh MD, PhD,